Understanding the MTHFR Gene: Your Complete Guide to Methylation and Nutrition

The MTHFR gene is arguably the most discussed gene in nutritional genomics, and for good reason. A variant in this single gene can influence everything from your energy levels and mood to your cardiovascular risk and how your body handles common vitamins. Yet despite its importance, many people with MTHFR variants live their entire lives without knowing, or without making the simple dietary adjustments that could make a significant difference.

In this comprehensive guide, we'll explore exactly what MTHFR does, what the most common variants mean for your health, and, most importantly, the evidence-based nutritional strategies you can use to optimise your methylation cycle.

What Is the MTHFR Gene?

MTHFR stands for methylenetetrahydrofolate reductase, an enzyme that plays a pivotal role in the folate cycle, the metabolic pathway responsible for converting dietary folate into its biologically active form, 5-methyltetrahydrofolate (5-MTHF). This active folate is the universal methyl donor required for the methylation of DNA, neurotransmitters, hormones, and hundreds of other molecules throughout the body.

Think of methylation as a molecular switch. When a methyl group (CH₃) attaches to a molecule, it can turn genes on or off, activate enzymes, break down hormones, produce neurotransmitters, and protect DNA from damage. Without adequate methylation, these processes falter, often subtly at first, then with increasingly significant effects over time.

The Two Key MTHFR Variants

C677T (rs1801133), The Most Common and Clinically Significant

The C677T polymorphism causes an alanine-to-valine substitution at position 222 of the enzyme. This structural change makes the enzyme thermolabile, meaning it becomes unstable and less efficient, particularly at normal body temperature.

• Heterozygous (CT genotype): One copy of the variant. Enzyme activity reduced by approximately 35%. Estimated to affect 30-40% of the population in many European countries.
• Homozygous (TT genotype): Two copies of the variant. Enzyme activity reduced by 60-70%. Affects approximately 10-15% of people of European descent and higher proportions in some Mediterranean populations.

People with the TT genotype typically have elevated homocysteine levels, a sulphur-containing amino acid that becomes toxic at high concentrations. Elevated homocysteine is an established independent risk factor for cardiovascular disease, stroke, and cognitive decline.

A1298C (rs1801131), The Secondary Variant

The A1298C polymorphism causes a glutamate-to-alanine change and primarily affects the enzyme's regulation of BH4 (tetrahydrobiopterin) production, a critical cofactor for the synthesis of serotonin, dopamine, and nitric oxide. Its effect on folate metabolism is milder than C677T, but its impact on neurotransmitter production can be clinically significant.

Compound heterozygosity, having one copy of C677T AND one copy of A1298C, can produce effects similar to being homozygous for C677T, with meaningful reductions in enzyme function and potential impacts on both methylation and neurotransmitter synthesis.

How MTHFR Variants Affect Your Health

Cardiovascular Risk

The most studied consequence of MTHFR variants is elevated plasma homocysteine. When the methylation cycle is impaired, homocysteine accumulates rather than being converted to methionine. High homocysteine damages the endothelial lining of blood vessels, promotes oxidative stress, increases platelet aggregation, and impairs nitric oxide production, all pathways linked to atherosclerosis and thrombosis.

Mental Health and Neurotransmitters

Methylation is essential for producing SAM-e (S-adenosylmethionine), the body's primary methyl donor. SAM-e is required for the synthesis of serotonin, dopamine, and norepinephrine. Impaired methylation has been associated in research with higher rates of depression, anxiety, and attention difficulties. The A1298C variant's impact on BH4 compounds this risk by further reducing neurotransmitter precursor availability.

Pregnancy and Foetal Development

Adequate folate and methylation are critical during conception and early pregnancy for proper neural tube closure. The MTHFR C677T TT genotype is associated with a 2-3 fold increased risk of neural tube defects when folate status is suboptimal. This is why women with known MTHFR variants are often advised to supplement with methylfolate rather than standard folic acid.

Detoxification Pathways

Methylation supports phase II liver detoxification. When methylation is impaired, the body's ability to neutralise and excrete toxins, heavy metals, and oestrogen metabolites may be compromised, potentially contributing to hormonal imbalances and toxic burden over time.

The Critical Distinction: Folic Acid vs. Methylfolate

This is where many well-intentioned supplement strategies go wrong. Folic acid, the synthetic form found in most supplements and fortified foods, must undergo multiple enzymatic conversions before the body can use it. The final conversion step requires the MTHFR enzyme. If your MTHFR is impaired, much of the folic acid you consume may remain unconverted and can even block your folate receptors, competing with the active form for uptake.

Individuals with MTHFR variants often benefit more from 5-methyltetrahydrofolate (5-MTHF), the pre-converted, biologically active form, than from standard folic acid supplementation.

Look for supplements labelled "methylfolate", "5-MTHF", "Metafolin", or "Quatrefolic" rather than "folic acid" if you carry MTHFR variants.

Nutritional Strategies for MTHFR Variants

Priority 1: Natural Food-Based Folate

Unlike folic acid, naturally occurring folate in food is already partially converted and doesn't require full MTHFR activity. Prioritise these high-folate foods:

• Dark leafy greens: Spinach (194 mcg/100g), rocket/arugula, kale, romaine lettuce
• Legumes: Lentils (181 mcg cooked/100g), black beans, chickpeas, edamame
• Asparagus: One of the richest sources at 149 mcg per 100g
• Avocado: Provides 81 mcg per 100g plus healthy fats for absorption
• Liver: Exceptionally rich in natural folate and B12 (1-2 servings per week)
• Broccoli and Brussels sprouts: 63-57 mcg per 100g respectively
• Citrus fruits: Oranges and fresh orange juice provide meaningful folate

Aim for 5+ servings of folate-rich vegetables daily. Note that folate is heat-sensitive, lightly cooking or eating raw where possible preserves more of the nutrient.

Priority 2: B12, The Methylation Partner

Vitamin B12 works directly with MTHFR in the methylation cycle. B12 deficiency can produce methylation impairment even with adequate folate. The most bioavailable forms for those with MTHFR variants are methylcobalamin and adenosylcobalamin rather than cyanocobalamin.

• Beef, lamb, and organ meats (highest concentrations)
• Oily fish: salmon, sardines, mackerel, tuna
• Eggs and dairy products
• For vegans: nutritional yeast and fortified plant milks (choose methylcobalamin-fortified)

Priority 3: Riboflavin (B2), The MTHFR Stabiliser

Research has demonstrated that riboflavin is a critical cofactor for the MTHFR enzyme. Adequate riboflavin intake has been shown to partially restore MTHFR activity in TT individuals and reduce homocysteine levels. Include: eggs, almonds, mushrooms, lean meats, and leafy greens.

Priority 4: Choline and Betaine, Alternative Methyl Donors

The body has a backup methylation pathway that uses betaine (trimethylglycine) and choline to convert homocysteine to methionine independently of MTHFR. This provides a meaningful safety net:

• Choline-rich foods: Eggs (yolks are particularly rich, 147mg per egg), beef liver, shrimp
• Betaine-rich foods: Beetroot, spinach, quinoa, wheat germ, sweet potato

What to Reduce

• Fortified foods high in synthetic folic acid: Many cereals and breads contain folic acid that may be problematic in MTHFR TT individuals
• Alcohol: Directly depletes folate and impairs methylation
• Excess methionine without cofactors: High animal protein without adequate B vitamins can raise homocysteine

Supplement Considerations

If dietary measures are insufficient, a targeted supplement protocol for MTHFR variants typically includes:

• Methylfolate (5-MTHF): 400-800 mcg/day (start low, some people experience "overmethylation" symptoms like irritability at higher doses)
• Methylcobalamin (B12): 500-1000 mcg/day
• Riboflavin (B2): 10-15 mg/day
• P5P (active B6): Supports the transsulfuration pathway for homocysteine clearance
• Trimethylglycine (TMG/betaine): 500-1000 mg if homocysteine remains elevated

Always introduce methylfolate gradually. Some individuals, particularly those with anxiety, can experience a paradoxical reaction to high-dose methylation support. Start with 100-200 mcg and increase slowly under practitioner guidance.

Getting Tested and Working with Your Doctor

If you suspect MTHFR is impacting your health, ask your doctor about:

• Plasma homocysteine levels: Optimal is below 9 μmol/L; above 15 μmol/L requires intervention
• Serum folate and B12: Aim for the upper half of the reference range
• MTHFR genetic testing: Available through your FuelYourDNA report or clinical testing
• RBC folate: Better indicator of long-term folate status than serum folate

Key Takeaways

• MTHFR variants (particularly C677T TT) reduce the enzyme's ability to activate folate by up to 70%, affecting methylation throughout the body
• The most immediate consequence is elevated homocysteine, a cardiovascular and cognitive risk marker, and reduced neurotransmitter synthesis
• Choose food-based natural folate and methylfolate supplements over synthetic folic acid
• B2 (riboflavin) is uniquely important, it stabilises the MTHFR enzyme itself
• Test your homocysteine levels; this gives you a functional readout of your methylation status regardless of genotype

Scientific References

Key research informing this article includes studies published in the American Journal of Clinical Nutrition, the Journal of Nutrition, and Human Genetics on MTHFR variants, folate metabolism, and homocysteine. The evidence base for riboflavin's role in MTHFR function is particularly well-established in the work of Rima Rozen and the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA).